Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | GAA | P10253 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MPI | P34949 | 1/20 | 1.00 |
| ▸ | NAMPT | P43490 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.82 |
| ▸ | XDH | P47989 | 4/20 | 0.82 |
| ▸ | MAOA | P21397 | 3/20 | 0.82 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.82 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.82 |
| ▸ | CA12 | O43570 | 1/20 | 0.82 |
| ▸ | CA2 | P00918 | 1/20 | 0.82 |
| ▸ | CA4 | P22748 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myricitrin SCHEMBL30427168 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL30637444 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL13240936 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL6361658 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL12640019 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL226022 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL226023 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL22788153 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL22822137 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA | |
| Myricitrin SCHEMBL29615613 | 1.00 | P4HB (1.00) | P4HBKDM4EMAPTPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12454714-B2 | Monbretin A (MbA) synthesis using a heterologous nucleic acid(s) encoding A MbA pathway enzyme | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-10-28 | — | — | US | claimed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | claimed |
| CN-114460189-B | Method for screening differential markers of ultra-high pressure treated blueberry juice and heat treated blueberry juice | 沈阳农业大学 | 2024-04-12 | — | — | CN | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-11439655-B2 | Compounds for use in wound healing and angiogenesis | UNIVERSITY OF SOUTH CAROLINA (US) | 2022-09-13 | — | — | US | claimed |
| CN-114460189-A | Method for screening difference markers of blueberry juice subjected to ultrahigh pressure treatment and blueberry juice subjected to heat treatment | 沈阳农业大学 | 2022-05-10 | — | — | CN | claimed |
| US-20210317497-A1 | MONBRETIN A (MBA) SYNTHESIS USING A HETEROLOGOUS NUCLEIC ACID(S) ENCODING A MBA PATHWAY ENZYME | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-10-14 | — | — | US | claimed |
| US-10028970-B2 | Composition comprising cashew apple extract | NATUREX (FR) | 2018-07-24 | — | — | US | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| JP-6293654-A | — | — | None | — | — | JP | disclosed |
| US-12630450-B1 | Somatic embryonic cell suspension for wastewater treatment | King Faisal University (SA) | 2026-05-19 | — | — | US | disclosed |
| US-20260124225-A1 | THERAPEUTIC COMPOSITIONS AND METHODS FOR USING SAME | KARNICK WILLIAM (US) | 2026-05-07 | — | — | US | disclosed |
| CN-120937891-A | Composition for reducing content of advanced glycosylation end product of food and application thereof | 中国海洋大学 | 2025-11-14 | — | — | CN | disclosed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | disclosed |
| CN-1298734-A | Plant medicine for treating cardiovascular medicine and its preparing process | WUHAN INST OF PHYTOLOGY CHINES (CN) | 2001-06-13 | — | — | CN | disclosed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | disclosed |
| JP-H06293654-A | ACTIVE OXYGEN SCAVENGING AGENT AND ALDOSE REDUCTASE INHIBITING AGENT | NIPPON MEKTRON LTD | 1994-10-21 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124225-A1 | THERAPEUTIC COMPOSITIONS AND METHODS FOR USING SAME | GCG, MC4R, GLP1R | P4HB 4451/4885KDM4E 1278/4885MAPT 1901/4885 |
| US-11439655-B2 | Compounds for use in wound healing and angiogenesis | CUTA, VEGFA, MYB | P4HB 2194/4885KDM4E 3724/4885MAPT 3977/4885 |
| US-12630450-B1 | Somatic embryonic cell suspension for wastewater treatment | ALPG, PROX1, KIT | P4HB 4827/4885KDM4E 542/4885MAPT 3642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.